Stay updated on VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.

Latest updates to the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry v3.5.4 has been added and the previous revision v3.5.3 has been removed, indicating an update to the documented revision history.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedThe study record shows updated metadata: the sponsor/links section and “last update” timing reflect a more recent posting (2026-04-24 and 2026-04-10/2026-04). Some study location entries have also changed by removing added ZIP+4 details, while the core study description and clinical components remain the same.SummaryDifference0.5%

- Check45 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision: v3.4.3 was added to the documentation and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check109 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, a minor backend/UI update that does not modify study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIS649 Safety and Efficacy in IgA Nephropathy Clinical Trial page.